| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |